4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Systems biology of Mycobacterium tuberculosis (SYSTEMTB)
Date du début: 1 avr. 2010, Date de fin: 30 sept. 2014,
Tuberculosis (TB) is a re-emerging global health threat caused by Mycobacterium tuberculosis (Mtb). One third of the world's population is infected with Mtb and new infections occur at a rate of one per second. Despite global research efforts, mechanisms underlying pathogenesis, virulence and persistence of Mtb infection remain poorly understood. Simple reductionist approaches are insufficient to ...
Voir le projet
14
Participants partenaires
TERMINÉ
DEVELOPMENT OF DIAMOND INTRACELLULAR NANOPROBES FOR ONCOGEN TRANSFORMATION DYNAMICS MONITORING IN LIVING CELLS (DINAMO)
Date du début: 1 mai 2010, Date de fin: 30 avr. 2013,
Dynamic information about biomolecular processes in living cells is important for fundamental understanding of cellular functions, which is one of the primary targets of molecular cell-biology with important applications to pharmacology. However fur further progress in this field, and this specifically for monitoring genomic processes, there is immense need for developing sensing and detection tec ...
Voir le projet
8
Participants partenaires
TERMINÉ
New Horizons for Mass Spectrometry (HORIZOMS)
Date du début: 1 juil. 2009, Date de fin: 31 mars 2013,
This project of basic research in chemistry tackles the challenge to close the wide gap between chemical and physical processes occurring in liquid solution and sophisticated studies of model systems in the idealized gas phase. By such the project aims to reach a convergence between the microscopic and macroscopic world. To this end, the planned research will span the range from isolated atoms in ...
Voir le projet
1
Participant partenaire
TERMINÉ
"TARGETING HIV INTEGRATION CO-FACTORS, TARGETING CELLULAR PROTEINS DURING NUCLEAR IMPORT OR INTEGRATION OF HIV" (THINC)
Date du début: 1 mars 2008, Date de fin: 29 févr. 2012,
"Standard therapy of infection with the human immunodeficiency virus type 1 (HIV-1) is based on potent cocktails of drugs targeting viral proteins. This treatment is associated with severe side effects and is almost unaffordable for the patients living in sub-Saharan Africa. Incomplete suppression of HIV replication results in drug-resistance. Therefore, a continued research effort is required to ...
Voir le projet